AVERY W CATLIN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for AVERY W CATLIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of AVERY W CATLIN. AVERY W CATLIN is Sr. VP & CFO in Celldex Therapeutics, Inc. ($AVAN) and Director in Corbus Pharmaceuticals Holdings, Inc. ($CRBP) and Director in Provention Bio, Inc. ($PRVB).
Latest Insider Trading Transactions of AVERY W CATLIN
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CLDX, CRBP, PRVB
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 14 2021 | PRVB | Provention Bio, In ... | CATLIN AVERY W | Director | Option Exercise | A | 6.80 | 23,000 | 156,400 | 23,000 | |
| Jul 16 2020 | PRVB | Provention Bio, In ... | CATLIN AVERY W | Director | Option Exercise | A | 12.62 | 22,200 | 280,164 | 22,200 | |
| May 22 2020 | CRBP | Corbus Pharmaceuti ... | CATLIN AVERY W | Director | Option Exercise | A | 7.30 | 40,500 | 295,650 | 40,500 | |
| Jun 28 2019 | CRBP | Corbus Pharmaceuti ... | CATLIN AVERY W | Director | Option Exercise | A | 7.31 | 33,300 | 243,423 | 33,300 | |
| Jun 25 2019 | PRVB | Provention Bio, In ... | CATLIN AVERY W | Director | Option Exercise | A | 12.54 | 24,000 | 300,960 | 24,000 | |
| Dec 27 2018 | PRVB | Provention Bio, In ... | CATLIN AVERY W | Director | Buy | P | 1.85 | 5,000 | 9,250 | 20,000 | 15 K to 20 K (+33.33 %) |
| Dec 27 2018 | PRVB | Provention Bio, In ... | CATLIN AVERY W | Director | Buy | P | 1.90 | 5,000 | 9,500 | 15,000 | 10 K to 15 K (+50.00 %) |
| Nov 13 2018 | PRVB | Provention Bio, In ... | CATLIN AVERY W | Director | Buy | P | 3.15 | 10,000 | 31,500 | 10,000 | 0 to 10 K |
| Sep 05 2018 | PRVB | Provention Bio, In ... | CATLIN AVERY W | Director | Option Exercise | A | 3.88 | 128,981 | 500,446 | 128,981 | |
| May 29 2018 | CRBP | Corbus Pharmaceuti ... | CATLIN AVERY W | Director | Option Exercise | A | 5.93 | 34,000 | 201,620 | 34,000 | |
| May 26 2017 | CRBP | Corbus Pharmaceuti ... | CATLIN AVERY W | Director | Option Exercise | A | 6.75 | 30,500 | 205,875 | 30,500 | |
| May 12 2017 | CRBP | Corbus Pharmaceuti ... | CATLIN AVERY W | Director | Buy | P | 6.15 | 5,000 | 30,741 | 47,000 | 42 K to 47 K (+11.90 %) |
| Nov 22 2016 | CRBP | Corbus Pharmaceuti ... | CATLIN AVERY W | Director | Buy | P | 7.55 | 2,000 | 15,100 | 42,000 | 40 K to 42 K (+5.00 %) |
| Sep 07 2016 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | M | 2.80 | 10,000 | 28,000 | 25,000 | |
| Sep 07 2016 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Buy | M | 2.80 | 10,000 | 28,000 | 83,586 | 73.6 K to 83.6 K (+13.59 %) |
| Jun 09 2016 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | A | 4.72 | 135,000 | 637,200 | 135,000 | |
| Jun 06 2016 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | M | 4.50 | 2,847 | 12,812 | 5,000 | |
| Jun 06 2016 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | M | 2.80 | 20,000 | 56,000 | 0 | |
| Jun 06 2016 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Buy | M | 4.50 | 2,847 | 12,812 | 73,586 | 70.7 K to 73.6 K (+4.02 %) |
| Jun 06 2016 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Buy | M | 2.80 | 20,000 | 56,000 | 70,739 | 50.7 K to 70.7 K (+39.42 %) |
| May 31 2016 | CRBP | Corbus Pharmaceuti ... | CATLIN AVERY W | Director | Option Exercise | A | 3.00 | 50,000 | 150,000 | 50,000 | |
| Mar 10 2016 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | M | 2.80 | 15,000 | 42,000 | 20,000 | |
| Mar 10 2016 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Buy | M | 2.80 | 15,000 | 42,000 | 50,739 | 35.7 K to 50.7 K (+41.97 %) |
| Nov 25 2015 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | M | 8.52 | 25,000 | 213,000 | 0 | |
| Nov 25 2015 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Sell | S | 18.00 | 25,000 | 450,000 | 35,109 | 60.1 K to 35.1 K (-41.59 %) |
| Nov 25 2015 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Buy | M | 8.52 | 25,000 | 213,000 | 60,109 | 35.1 K to 60.1 K (+71.21 %) |
| Sep 14 2015 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | M | 4.50 | 10,000 | 45,000 | 7,847 | |
| Sep 14 2015 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Buy | M | 4.50 | 10,000 | 45,000 | 35,109 | 25.1 K to 35.1 K (+39.83 %) |
| Aug 19 2015 | CRBP | Corbus Pharmaceuti ... | CATLIN AVERY W | Director | Buy | P | 1.90 | 8,212 | 15,603 | 40,000 | 31.8 K to 40 K (+25.83 %) |
| Aug 18 2015 | CRBP | Corbus Pharmaceuti ... | CATLIN AVERY W | Director | Buy | P | 1.90 | 1,788 | 3,397 | 31,788 | 30 K to 31.8 K (+5.96 %) |
| Aug 18 2015 | CRBP | Corbus Pharmaceuti ... | CATLIN AVERY W | Director | Buy | P | 1.95 | 5,000 | 9,750 | 30,000 | 25 K to 30 K (+20.00 %) |
| Aug 18 2015 | CRBP | Corbus Pharmaceuti ... | CATLIN AVERY W | Director | Buy | P | 1.94 | 5,000 | 9,695 | 25,000 | 20 K to 25 K (+25.00 %) |
| Aug 17 2015 | CRBP | Corbus Pharmaceuti ... | CATLIN AVERY W | Director | Option Exercise | A | 1.97 | 20,000 | 39,400 | 20,000 | |
| Jun 16 2015 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | M | 8.52 | 25,000 | 213,000 | 0 | |
| Jun 16 2015 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Sell | S | 24.59 | 25,000 | 614,753 | 24,609 | 49.6 K to 24.6 K (-50.39 %) |
| Jun 16 2015 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Buy | M | 8.52 | 25,000 | 213,000 | 49,609 | 24.6 K to 49.6 K (+101.59 %) |
| Jun 11 2015 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | A | 25.41 | 92,000 | 2,337,720 | 92,000 | |
| Jun 09 2015 | CRBP | Corbus Pharmaceuti ... | CATLIN AVERY W | Director | Buy | P | 3.10 | 20,000 | 62,000 | 20,000 | 0 to 20 K |
| Jan 08 2009 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | A | 8.52 | 61,000 | 519,720 | 61,000 | |
| Jan 08 2009 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Grant | A | 0.00 | 5,868 | 0 | 7,759 | 1.9 K to 7.8 K (+310.31 %) |
| Jan 05 2009 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Buy | L | 6.73 | 100 | 673 | 100 | 0 to 100 |
| Mar 11 2008 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | A | 8.16 | 183,333 | 1,495,997 | 183,333 | |
| Jul 02 2007 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Buy | L | 0.71 | 500 | 353 | 21,500 | 21 K to 21.5 K (+2.38 %) |
| Jan 08 2007 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | A | 1.36 | 25,000 | 33,875 | 304,000 | |
| Aug 16 2006 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Buy | P | 1.35 | 5,000 | 6,750 | 21,000 | 16 K to 21 K (+31.25 %) |
| Jul 03 2006 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Buy | L | 1.37 | 500 | 685 | 16,000 | 15.5 K to 16 K (+3.23 %) |
| Jan 10 2006 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | A | 2.04 | 25,000 | 51,000 | 279,000 | |
| Nov 22 2005 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | C | 1.14 | 5,000 | 5,700 | 254,000 | |
| Nov 22 2005 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Buy | M | 1.14 | 5,000 | 5,700 | 15,500 | 10.5 K to 15.5 K (+47.62 %) |
| Jul 06 2005 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Buy | L | 0.99 | 500 | 497 | 10,500 | 10 K to 10.5 K (+5.00 %) |
| Jan 05 2005 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | A | 2.08 | 12,000 | 24,900 | 259,000 | |
| Aug 04 2004 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Buy | P | 1.83 | 3,500 | 6,388 | 10,000 | 6.5 K to 10 K (+53.85 %) |
| Jul 02 2004 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Buy | L | 2.26 | 500 | 1,131 | 6,500 | 6 K to 6.5 K (+8.33 %) |
Page: 1